Pneumococcal 23-valent vaccine (Fosun Adgenvax)

23价肺炎球菌多糖疫苗（ 复星安特金）

Report date: 2024/07/26 15:54:03

Base Information

Drug NamePneumococcal 23-valent vaccine (Fosun Adgenvax)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFosun Adgenvax Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFosun Adgenvax Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A